Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.
Discover how bispecific antisense oligonucleotides targeting Bcl-2 and Bcl-xL proteins are revolutionizing cancer therapy by flipping cancer's apoptotic switch.